Andreas Rummelt - Net Worth and Insider Trading

Andreas Rummelt Net Worth

The estimated net worth of Andreas Rummelt is at least $2 Million dollars as of 2024-05-27. Andreas Rummelt is the Director of Alexion Pharmaceuticals Inc and owns about 12,786 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $2 Million. Details can be seen in Andreas Rummelt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andreas Rummelt has not made any transactions after 2014-08-25 and currently still holds the listed stock(s).

Transaction Summary of Andreas Rummelt

To

Andreas Rummelt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andreas Rummelt owns 1 companies in total, including Alexion Pharmaceuticals Inc (ALXN) .

Click here to see the complete history of Andreas Rummelt’s form 4 insider trades.

Insider Ownership Summary of Andreas Rummelt

Ticker Comapny Transaction Date Type of Owner
ALXN Alexion Pharmaceuticals Inc 2020-05-14 director

Andreas Rummelt Latest Holdings Summary

Andreas Rummelt currently owns a total of 1 stock. Andreas Rummelt owns 12,786 shares of Alexion Pharmaceuticals Inc (ALXN) as of August 25, 2014, with a value of $2 Million.

Latest Holdings of Andreas Rummelt

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXN Alexion Pharmaceuticals Inc 2014-08-25 12,786 182.50 2,333,445

Holding Weightings of Andreas Rummelt


Andreas Rummelt Form 4 Trading Tracker

According to the SEC Form 4 filings, Andreas Rummelt has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 5,052 shares on August 25, 2014, which brought Andreas Rummelt around $861,518.

Insider Trading History of Andreas Rummelt

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andreas Rummelt Trading Performance

GuruFocus tracks the stock performance after each of Andreas Rummelt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andreas Rummelt is 7.65%. GuruFocus also compares Andreas Rummelt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andreas Rummelt within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Andreas Rummelt's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Andreas Rummelt

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.41
Relative Return to S&P 500(%) 4.88

Andreas Rummelt Ownership Network

Ownership Network List of Andreas Rummelt

No Data

Ownership Network Relation of Andreas Rummelt


Andreas Rummelt Owned Company Details

What does Alexion Pharmaceuticals Inc do?

Who are the key executives at Alexion Pharmaceuticals Inc?

Andreas Rummelt is the director of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .

Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alexion Pharmaceuticals Inc Insider Transactions

No Available Data

Andreas Rummelt Mailing Address

Above is the net worth, insider trading, and ownership report for Andreas Rummelt. You might contact Andreas Rummelt via mailing address: C/o Alexion Pharmaceuticals, Inc. 352 Knotter Drive Cheshire Ct 06410.

Discussions on Andreas Rummelt

No discussions yet.